Drug Metabolism Letters
Title:Alam K et al. (2018) Drug Metabolism Letters; 12, 24-32.
Volume: 12 Issue: 2
Author(s): Tristan M. Sissung, Cindy Chau, Douglas K. Price and William D. Figg*
Affiliation:
- Clinical Pharmacology Program, Office of the Clinical Director, and the Molecular Pharmacology Section, Genitourinary Malignancies Branch, National Cancer Institute, Bethesda, MD,United States
Export Options
About this article
Cite this article as:
Sissung M. Tristan, Chau Cindy, Price K. Douglas and Figg D. William*, Alam K et al. (2018) Drug Metabolism Letters; 12, 24-32., Drug Metabolism Letters 2018; 12 (2) . https://dx.doi.org/10.2174/1872312812999180724145725
DOI https://dx.doi.org/10.2174/1872312812999180724145725 |
Print ISSN 1872-3128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1874-0758 |
39
2
Related Articles
-
Recent Developments of Small Molecule EGFR Inhibitors Based on the Quinazoline Core Scaffolds
Anti-Cancer Agents in Medicinal Chemistry FDG-PET/CT and SPECT/CT in Oncology
Current Medical Imaging Lemon Juice Mediated Synthesis of 3-Substituted Quinazolin-4(3H)-Ones and their Pharmacological Evaluation
Anti-Cancer Agents in Medicinal Chemistry Signal Transduction Pathways of Taxanes-Induced Apoptosis
Current Medicinal Chemistry - Anti-Cancer Agents PET Tracers Based on Zirconium-89
Current Radiopharmaceuticals Synthetic Vaccines: The Role of Adjuvants in Immune Targeting
Current Medicinal Chemistry Determination of Human Serum α1-Acid Glycoprotein and Albumin Binding of Various Marketed and Preclinical Kinase Inhibitors
Current Medicinal Chemistry Natural Radioprotective Agents: An Overview
Current Organic Chemistry Antigenic Peptide Vaccination: Provoking Immune Response and Clinical Benefit for Cancer
Current Immunology Reviews (Discontinued) TLR7/9 Antagonists as Therapeutics for Immune-Mediated Inflammatory Disorders
Inflammation & Allergy - Drug Targets (Discontinued) Harnessing the Natural Pool of Polyketide and Non-ribosomal Peptide Family: A Route Map towards Novel Drug Development
Current Molecular Pharmacology Drug-Glycosidation and Drug Development
Mini-Reviews in Medicinal Chemistry “Letting the Air In” Can Set the Stage for Tumor Recurrences
Current Cancer Therapy Reviews Interaction of Isoflavones with the BCRP/ABCG2 Drug Transporter
Current Drug Metabolism Pharmacological Cyclin-Dependent Kinase Inhibitors (PCIs) as Potential Antiviral Drugs
Anti-Infective Agents in Medicinal Chemistry Current Development of ROS-Modulating Agents as Novel Antitumor Therapy
Current Cancer Drug Targets Editorial [Hot Topic: Stem Cells and Tissue Regeneration (Executive Guest Editor: Roberta Di Pietro)]
Current Pharmaceutical Design Pharmacogenetics, Regulation and Structural Properties of the Drugmetabolizing Enzymes Arylamine N-acetyltransferases
Current Pharmacogenomics Journey Describing the Cytotoxic Potential of Withanolides: A Patent Review
Recent Patents on Anti-Cancer Drug Discovery SPARC in Tumor Pathophysiology and as a Potential Therapeutic Target
Current Pharmaceutical Design